COVID-19 Self-testing Study
NCT05701878 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2024-02-16
Summary
The goal of this clinical trial is to understand how the introduction of an app-based intervention changes knowledge, attitudes, and practices on COVID-19 self-testing.
Conditions
Interventions
- BEHAVIORAL
-
SMARTest mobile app for COVID-19 self-testing
The mobile app has self-testing features and information with regard to self-testing and COVID-19.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Yael Hirsch-Moverman, PhD · Columbia University
-
Samuel K. Sia, PhD · Columbia University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-04-03
- Primary Completion
- 2023-09-06
- Completion
- 2023-09-06
Countries
- United States
Study Locations
More Related Trials
-
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
NCT04292730 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19
NCT05305547 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19 Molecular OTC At Home Test
NCT05704803 ·Status: COMPLETED ·Phase: NA
-
Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection
NCT05897541 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID
NCT04349371 ·Status: TERMINATED ·Phase: PHASE2
-
A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
NCT05387369 ·Status: RECRUITING
-
COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose
NCT05392075 ·Status: COMPLETED
-
Adaptive COVID-19 Treatment Trial (ACTT)
NCT04280705 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Obeldesivir in Nonhospitalized Participants With COVID-19
NCT05715528 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older
NCT04405076 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients
NCT04471051 ·Status: COMPLETED
-
Community Collaboration to Combat COVID-19 (C-FORWARD)
NCT04673292 ·Status: COMPLETED ·Phase: NA
-
A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
NCT04758273 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)
NCT05787444 ·Status: UNKNOWN
-
Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19
NCT04405570 ·Status: COMPLETED ·Phase: PHASE2
-
A Registry Study of Patients Hospitalized With Confirmed COVID-19
NCT05792865 ·Status: UNKNOWN
-
Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19)
NCT06360757 ·Status: TERMINATED
-
Clinical Trial of COVID-19 Vaccine(SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine) in Participants Aged 18 Years and Over
NCT05745545 ·Status: UNKNOWN ·Phase: NA
-
FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol
NCT05928507 ·Status: UNKNOWN
-
A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection
NCT05697055 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19
NCT05218356 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir
NCT05567952 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Remdesivir in Participants Below 18 Years Old With COVID-19
NCT04431453 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19
NCT04594343 ·Status: COMPLETED ·Phase: PHASE2